The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Research progress and clinical application of targeting medicines in the treatment against non-small cell lung cancer
Author(s): 
Pages: 691-697
Year: Issue:  11
Journal: World Clinical Drugs

Keyword:  非小细胞肺癌表皮生长因子受体血管内皮生长因子分子靶向治疗;
Abstract: 近年来分子靶向治疗已成为晚期非小细胞肺癌(NSCLC)临床治疗的一种新选择.目前NSCLC靶向治疗药物作用靶点的研究主要集中在表皮生长因子受体(EGFR)和血管内皮生长因子(VEGF).本文综述靶向药物及其联合治疗方案研究进展.
Related Articles
No related articles found